Consult the medical resource doctors trust

UpToDate is one of the most respected medical information resources in the world, used by over 360,000 doctors and thousands of patients to find answers to medical questions.

  • Content written by a faculty of over 4,000 physicians from leading medical institutions
  • Unbiased: free of advertising or pharmaceutical funding
  • Evidence-based treatment recommendations
  • Continuously updated to incorporate new medical findings

Related Searches

Secretin

INTRODUCTION

The field of endocrinology and the study of "hormones" began at the turn of the 20th century when Bayliss and Starling described a chemical substance in intestinal extracts that, when injected intravenously, stimulated pancreatic secretion [1]. They named this substance secretin because it caused the pancreas to secrete fluid when acid was present in the gut. This discovery led to a search for other chemical substances that when released from one tissue could excite or stimulate organ function in a different location. The Greek word "hormone," meaning "arise to activity," was used to designate these chemical messengers. It is now known that secretin stimulates pancreatic fluid and bicarbonate secretion leading to neutralization of acidic chyme in the intestine. Secretin also inhibits gastric acid release and intestinal motility.

MOLECULAR FORMS

Despite knowledge of physiological activity, it took more than 50 years for the chemical nature of the hormone secretin to be identified. The amino acid sequence was not determined until the 1960s [2]. Human secretin is a 27 amino-acid peptide, with a molecular weight of 3055 D. Its sequence is conserved across many mammalian species (algorithm 1).

Similar to other gastrointestinal peptides, secretin is amidated at the C-terminus. It is the founding member of the secretin/glucagon/vasoactive intestinal polypeptide family of gastrointestinal hormones. The gene structure of preprosecretin contains an N-terminal signal peptide, a short peptide sequence, secretin, and a C-terminal extension peptide [3]. The gene encoding secretin is selectively expressed in specialized enteroendocrine cells of the small intestine, called S cells. The details of secretin gene transcriptional control have been studied in secretin-producing islet cells [4].

TISSUE DISTRIBUTION

Immunocytochemistry has demonstrated that secretin-producing cells are found along the small intestine (figure 1) [5]. Other sites shown to produce secretin mRNA include the hypothalamus, cortex, cerebellum, and brain stem [3,6].

RECEPTORS

The secretin receptor is a member of the family of G protein coupled receptors (GPCRs), within which the secretin/glucagon family is structurally unique. This group consists of receptors for secretin, glucagon, calcitonin, parathyroid hormone, pituitary adenylyl cyclase-activating peptide (PACAP), vasoactive intestinal polypeptide (VIP), and others. These receptors lack structural signature sequences present in the rhodopsin/beta-adrenergic receptor family (such as a DRY motif — Asp-Arg-Tyr — at the end of the third transmembrane spanning domain), which appear to be important in receptor coupling to G proteins. Secretin binds to its specific heptahelical membrane receptor and activates the heterotrimeric G protein, Gs, leading to elevation of cellular cAMP levels. This second messenger begins the signaling cascade that initiates appropriate cell physiological responses. (See "Peptide hormone signal transduction and regulation".)

To continue reading this article you need to subscribe.

Read the rest of this article and others like it

The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use (click here) ©2010 UpToDate, Inc.
References Top
  1. Bayliss, WM, Starling, EH. The mechanism of pancreatic secretion. J Physiol 1902; 28:325.
  2. Mutt, V, Jorpes, JE, Magnusson, S. Structure of porcine secretin. The amino acid sequence. Eur J Biochem 1970; 15:513.
  3. Kopin, AS, Wheeler, MB, Leiter, AB. Secretin: Structure of the precursor and tissue distribution of the mRNA. Proc Natl Acad Sci U S A 1990; 87:2299.
  4. Nishitani, J, Rindi, G, Lopez, MJ, et al. Transcriptional regulation of secretin gene expression. J Clin Gastroenterol 1995; 21 Suppl 1:S50.
  5. Leiter, AB, Chey, WY, Kopin, AS. Secretin, 1st ed, Raven Press, New York 1994.
  6. Lee, SM, Yung, WH, Chen, L, Chow, BK. Expression and spatial distribution of secretin and secretin receptor in human cerebellum. Neuroreport 2005; 16:219.
  7. Ozcelebi, F, Holtmann, MH, Rentsch, RU, et al. Agonist-stimulated phosphorylation of the carboxyl-terminal tail of the secretin receptor. Mol Pharmacol 1995; 48:818.
  8. Shetzline, MA, Premont, RT, Walker, JK, et al. A role for receptor kinases in the regulation of class II G protein- coupled receptors. Phosphorylation and desensitization of the secretin receptor. J Biol Chem 1998; 273:6756.
  9. Walker, JK, Premont, RT, Barak, LS, et al. Properties of secretin receptor internalization differ from those of the beta(2)-adrenergic receptor. J Biol Chem 1999; 274:31515.
  10. Li, Y. Sensory signal transduction in the vagal primary afferent neurons. Curr Med Chem 2007; 14:2554.
  11. Schaffalitzky de Muckadell, OB, Fahrenkrug, J. Secretion pattern of secretin in man: Regulation by gastric acid. Gut 1978; 19:812.
  12. Li, P, Lee, KY, Chang, TM, Chey, WY. Mechanism of acid-induced release of secretin in rats. Presence of a secretin-releasing peptide. J Clin Invest 1990; 86:1474.
  13. You, CH, Rominger, JM, Chey, WY. Effects of atropine on the action and release of secretin in humans. Am J Physiol 1982; 242:G608.
  14. You, CH, Chey, WY. Secretin is an enterogastrone in humans. Dig Dis Sci 1987; 32:466.
  15. Boyer, JL, Bloomer, JR. Canalicular bile secretion in man. Studies utilizing the biliary clearance of (14C)mannitol. J Clin Invest 1974; 54:773.
  16. Dinoso, VP Jr, Meshkinpour, H, Lorber, SH, et al. Motor responses of the sigmoid colon and rectum to exogenous cholecystokinin and secretin. Gastroenterology 1973; 65:438.
  17. Cohen, S, Lipshutz, W. Hormonal regulation of human lower esophageal sphincter competence: Interaction of gastrin and secretin. J Clin Invest 1971; 50:449.
  18. Solomon, TE, Vanier, M, Morisset, J. Cell site and time course of DNA synthesis in pancreas after caerulein and secretin. Am J Physiol 1983; 245:G99.
  19. Talamini, G. Duodenal acidity may increase the risk of pancreatic cancer in the course of chronic pancreatitis: an etiopathogenetic hypothesis. JOP 2005; 6:122.
  20. Rindi, G, Ratineau, C, Ronco, A, et al. Targeted ablation of secretin-producing cells in transgenic mice reveals a common differentiation pathway with multiple enteroendocrine cell lineages in the small intestine. Development 1999; 126:4149.
  21. McGuigan, JE, Wolfe, MM. Secretin injection test in the diagnosis of gastrinoma. Gastroenterology 1980; 79:1324.
  22. Brady CE, 3d. Secretin provocation test in the diagnosis of Zollinger-Ellison syndrome. Am J Gastroenterol 1991; 86:129.
  23. Catalano, MF, Lahoti, S, Geenen, JE, Hogan, WJ. Prospective evaluation of endoscopic ultrasonography, endoscopic retrograde pancreatography, and secretin test in the diagnosis of chronic pancreatitis. Gastrointest Endosc 1998; 48:11.
  24. Raimondo, M, Imoto, M, DiMagno, EP. Rapid endoscopic secretin stimulation test and discrimination of chronic pancreatitis and pancreatic cancer from disease controls. Clin Gastroenterol Hepatol 2003; 1:397.
  25. Khalid, A, Peterson, M, Slivka, A. Secretin-stimulated magnetic resonance pancreaticogram to assess pancreatic duct outflow obstruction in evaluation of idiopathic acute recurrent pancreatitis: a pilot study. Dig Dis Sci 2003; 48:1475.
  26. Monill, J, Pernas, J, Clavero, J, et al. Pancreatic duct after pancreatoduodenectomy: morphologic and functional evaluation with secretin-stimulated MR pancreatography. AJR Am J Roentgenol 2004; 183:1267.
  27. Akisik, MF, Sandrasegaran, K, Aisen, AA, et al. Dynamic secretin-enhanced MR cholangiopancreatography. Radiographics 2006; 26:665.
  28. Horvath, K, Stefanatos, G, Sokolski, KN, et al. Improved social and language skills after secretin administration in patients with autistic spectrum disorders. J Assoc Acad Minor Phys 1998; 9:9.
  29. Sandler, AD, Sutton, KA, DeWeese, J, et al. Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder. N Engl J Med 1999; 341:1801.
  30. Esch, BE, Carr, JE. Secretin as a treatment for autism: a review of the evidence. J Autism Dev Disord 2004; 34:543.
white circle LOG IN
white circle DEMO